Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
3
×
boston university
3
×
clinical trials
life sciences
national blog main
new york blog main
san diego blog main
san francisco blog main
boston
deals
eli lilly
fda
indiana blog main
national top stories
new york top stories
raleigh-durham blog main
san diego top stories
san francisco top stories
seattle blog main
startups
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
akcea therapeutics
alez azar
alnylam pharmaceuticals
alzheimer's disease
antibiotics
arrowmark partners
axial spondyloarthritis
barry greene
bausch health
beta bionics
bigfoot biomedical
biogen
boulder/denver blog main
What
patients
ago
alnylam
approval
approve
awaits
beta
bio
biogen’s
biological
bionics
biopharmaceutical
blood
closed
companies
convo
crossed
decades
decision
developing
device
diabetes
discovered
driven
drug
earlier
failures
fda
fingers
friday
heads
historic
key
levels
littered
manages
medical
medicine
million
monitors
Language
Current search:
biotech
×
" boston top stories "
×
" boston university "
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
